PHAT
Price
$4.10
Change
+$0.08 (+1.99%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
279.24M
19 days until earnings call
SCPH
Price
$2.50
Change
-$0.09 (-3.46%)
Updated
Apr 24, 02:48 PM (EDT)
Capitalization
131.24M
26 days until earnings call
Ad is loading...

PHAT vs SCPH

Header iconPHAT vs SCPH Comparison
Open Charts PHAT vs SCPHBanner chart's image
Phathom Pharmaceuticals
Price$4.10
Change+$0.08 (+1.99%)
Volume$28.82K
Capitalization279.24M
scPharmaceuticals
Price$2.50
Change-$0.09 (-3.46%)
Volume$500
Capitalization131.24M
PHAT vs SCPH Comparison Chart
Loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHAT vs. SCPH commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a Hold and SCPH is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (PHAT: $4.01 vs. SCPH: $2.59)
Brand notoriety: PHAT and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 85% vs. SCPH: 36%
Market capitalization -- PHAT: $279.24M vs. SCPH: $131.24M
PHAT [@Biotechnology] is valued at $279.24M. SCPH’s [@Biotechnology] market capitalization is $131.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both PHAT and SCPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 2 TA indicator(s) are bullish while SCPH’s TA Score has 5 bullish TA indicator(s).

  • PHAT’s TA Score: 2 bullish, 5 bearish.
  • SCPH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than PHAT.

Price Growth

PHAT (@Biotechnology) experienced а -5.09% price change this week, while SCPH (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

PHAT is expected to report earnings on Aug 07, 2025.

SCPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($279M) has a higher market cap than SCPH($131M). SCPH YTD gains are higher at: -26.836 vs. PHAT (-50.616). SCPH has higher annual earnings (EBITDA): -71.31M vs. PHAT (-261.52M). PHAT has more cash in the bank: 297M vs. SCPH (91.5M). SCPH has less debt than PHAT: SCPH (52.5M) vs PHAT (202M). PHAT has higher revenues than SCPH: PHAT (55.3M) vs SCPH (30.3M).
PHATSCPHPHAT / SCPH
Capitalization279M131M213%
EBITDA-261.52M-71.31M367%
Gain YTD-50.616-26.836189%
P/E RatioN/AN/A-
Revenue55.3M30.3M183%
Total Cash297M91.5M325%
Total Debt202M52.5M385%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHATSCPH
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 24 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEWX8.820.18
+2.08%
Baillie Gifford Emer Mkt Ex Chn Instl
IENIX28.50N/A
N/A
Invesco Energy R5
SFSLX24.51N/A
N/A
1919 Financial Services C
CPODX42.22N/A
N/A
Morgan Stanley Insight I
BROAX20.08N/A
N/A
BlackRock Advantage International Inv A

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with BEAM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-0.77%
BEAM - SCPH
44%
Loosely correlated
+3.87%
ABCL - SCPH
43%
Loosely correlated
+0.79%
XERS - SCPH
42%
Loosely correlated
+0.73%
CRSP - SCPH
41%
Loosely correlated
-1.76%
AURA - SCPH
41%
Loosely correlated
+0.88%
More